Implementation Science

Even the most promising therapies can falter after clinical trials if they are not adopted in real-world practice. Implementation Science (ImpSci) bridges the gap between drug development and real-world healthcare adoption. By focusing on how treatments are introduced and sustained, ImpSci ensures your innovative pharmaceutical, biotech, or medtech products achieve their full potential.

photo illustration of woman holding child at doctor's office with blue overaly

Why Implementation Science Matters for Pharma Innovation

Developing a new drug is only part of the journey; the next challenge is real-world adoption. Your groundbreaking therapy may face hurdles upon launch, including:

  • providers hesitating to prescribe unfamiliar treatments
  • patients struggling with adherence
  • payers being cautious with reimbursement
  • health systems struggling to integrate new therapies into existing workflows

These barriers can lead to delays, inefficiencies, or inequities in patient access. Our team of experts can help you proactively identify and address these real-world challenges early, rather than leaving adoption to chance. By tackling these issues, Implementation Science services help close the “last mile” gap in healthcare innovation and powers your product development process by anticipating real-world needs and constraints.

Implementation Science at RTI Health Solutions

Why Implementation Science is Vital for Pharma Innovation
Pharmaceutical companies now have an opportunity to redefine how they deliver healthcare innovations. By prioritizing implementation science, companies can bridge the gap between discovery and delivery, ensuring therapies achieve their full potential. It is not only about better evidence, but also about better outcomes, better adoption, and better systems.

How We Can Help You

RTI-HS operationalizes Implementation Science with multidisciplinary expertise. We integrate insights from clinical research, medical affairs, real-world evidence (RWE), health economics, and stakeholder engagement into a layered, systems-thinking approach. Our cross-functional team works in unison, ensuring implementation is strategically integrated into study design, development, and real-world translation. This comprehensive approach considers scientific evidence, market dynamics, provider practices, patient perspectives, and policy environments as interconnected pieces. Using established frameworks and rigorous analytics, we identify facilitators and barriers. This comprehensive, systems-thinking perspective enables RTI-HS to craft tailored strategies—ensuring that by launch day the science, stakeholders, and system are all aligned for success.